Skip to main content
Erschienen in: Obesity Surgery 12/2020

16.09.2020 | Original Contributions

Which Factors Correlate with Marginal Ulcer After Surgery for Obesity?

verfasst von: Duarte-Chavez Rodrigo, Stoltzfus Jill, Marino Daniel, Chaput Kimberly, El Chaar Maher

Erschienen in: Obesity Surgery | Ausgabe 12/2020

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Marginal ulcer is one of the most common complications after Roux-en-Y gastric bypass and is defined as an ulceration of any depth at or near the gastrojejunal anastomosis. Different risk factors have been advocated to be the causative agent.

Materials and Methods

The weighted discharges from the Nationwide Inpatient Sample from 2003 to 2011 were used to assess for risk factors to develop marginal ulcer such as Helicobacter pylori infection, chronic nonsteroidal anti-inflammatory use, chronic aspirin use, alcohol dependence, smoking, hypertension, and diabetes mellitus type II.

Results

Chronic nonsteroidal anti-inflammatory drug use was the most significant risk factor for marginal ulcer, followed by Helicobacter pylori infection, obstructive sleep apnea, female sex, smoking, and alcohol dependence in decreasing order. Diabetes mellitus and hypertension were found to slightly increase the risk for marginal ulcer. The use of aspirin was found to be a minor risk factor during univariate analysis but a protective factor during multivariate analysis.

Conclusions

Multiple well-documented single factors are related to the genesis of a marginal ulcer, although it is likely that a combination of risk factors is responsible for this problem. These risk factors should be identified and removed or controlled.
Literatur
1.
Zurück zum Zitat Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357(8):753–61.PubMed Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357(8):753–61.PubMed
2.
Zurück zum Zitat Aminian A, Daigle CR, Romero-Talamas H, et al. Risk prediction of complications of metabolic syndrome before and 6 years after gastric bypass. Surg Obes Relat Dis. 2014;10(4):576–82.PubMed Aminian A, Daigle CR, Romero-Talamas H, et al. Risk prediction of complications of metabolic syndrome before and 6 years after gastric bypass. Surg Obes Relat Dis. 2014;10(4):576–82.PubMed
3.
Zurück zum Zitat Ogden CL, Carroll MD, Kit BK, et al. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA. 2014;311(8):806–14.PubMedPubMedCentral Ogden CL, Carroll MD, Kit BK, et al. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA. 2014;311(8):806–14.PubMedPubMedCentral
4.
Zurück zum Zitat Hales CM, Fryar CD, Carroll MD, et al. Differences in obesity prevalence by demographic characteristics and urbanization level among adults in the United States, 2013-2016. JAMA. 2018;319(23):2419–29.PubMedPubMedCentral Hales CM, Fryar CD, Carroll MD, et al. Differences in obesity prevalence by demographic characteristics and urbanization level among adults in the United States, 2013-2016. JAMA. 2018;319(23):2419–29.PubMedPubMedCentral
5.
Zurück zum Zitat Bradley 3rd JF, Ross SW, Christmas AB, et al. Complications of bariatric surgery: the acute care surgeon’s experience. Am J Surg. 2015;210(3):456–61.PubMed Bradley 3rd JF, Ross SW, Christmas AB, et al. Complications of bariatric surgery: the acute care surgeon’s experience. Am J Surg. 2015;210(3):456–61.PubMed
6.
Zurück zum Zitat El Chaar M, Claros L, Ezeji GC, et al. Improving outcome of bariatric surgery: best practices in an accredited surgical center. Obes Surg. 2014;24(7):1057–63.PubMed El Chaar M, Claros L, Ezeji GC, et al. Improving outcome of bariatric surgery: best practices in an accredited surgical center. Obes Surg. 2014;24(7):1057–63.PubMed
7.
Zurück zum Zitat Ma IT, Madura 2nd JA. Gastrointestinal complications after bariatric surgery. Gastroenterol Hepatol (N Y). 2015;11(8):526–35. Ma IT, Madura 2nd JA. Gastrointestinal complications after bariatric surgery. Gastroenterol Hepatol (N Y). 2015;11(8):526–35.
9.
Zurück zum Zitat Brethauer SA, Kim J, el Chaar M, et al. Standardized outcomes reporting in metabolic and bariatric surgery. Surg Obes Relat Dis. 2015;11(3):489–506.PubMed Brethauer SA, Kim J, el Chaar M, et al. Standardized outcomes reporting in metabolic and bariatric surgery. Surg Obes Relat Dis. 2015;11(3):489–506.PubMed
10.
Zurück zum Zitat Robert M, Espalieu P, Pelascini E, et al. Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial. Lancet. 2019;393(10178):1299–309.PubMed Robert M, Espalieu P, Pelascini E, et al. Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial. Lancet. 2019;393(10178):1299–309.PubMed
11.
Zurück zum Zitat El-Hayek K, Timratana P, Shimizu H, et al. Marginal ulcer after Roux-en-Y gastric bypass: what have we really learned? Surg Endosc. 2012;26(10):2789–96.PubMed El-Hayek K, Timratana P, Shimizu H, et al. Marginal ulcer after Roux-en-Y gastric bypass: what have we really learned? Surg Endosc. 2012;26(10):2789–96.PubMed
12.
Zurück zum Zitat Huang CS, Forse RA, Jacobson BC, et al. Endoscopic findings and their clinical correlations in patients with symptoms after gastric bypass surgery. Gastrointest Endosc. 2003;58(6):859–66.PubMed Huang CS, Forse RA, Jacobson BC, et al. Endoscopic findings and their clinical correlations in patients with symptoms after gastric bypass surgery. Gastrointest Endosc. 2003;58(6):859–66.PubMed
13.
Zurück zum Zitat Bhayani NH, Oyetunji TA, Chang DC, et al. Predictors of marginal ulcers after laparoscopic Roux-en-Y gastric bypass. J Surg Res. 2012;177(2):224–7.PubMed Bhayani NH, Oyetunji TA, Chang DC, et al. Predictors of marginal ulcers after laparoscopic Roux-en-Y gastric bypass. J Surg Res. 2012;177(2):224–7.PubMed
14.
Zurück zum Zitat Rasmussen JJ, Fuller W, Ali MR. Marginal ulceration after laparoscopic gastric bypass: an analysis of predisposing factors in 260 patients. Surg Endosc. 2007;21(7):1090–4.PubMed Rasmussen JJ, Fuller W, Ali MR. Marginal ulceration after laparoscopic gastric bypass: an analysis of predisposing factors in 260 patients. Surg Endosc. 2007;21(7):1090–4.PubMed
15.
Zurück zum Zitat Coblijn UK, Goucham AB, Lagarde SM, et al. Development of ulcer disease after Roux-en-Y gastric bypass, incidence, risk factors, and patient presentation: a systematic review. Obes Surg. 2014;24(2):299–309.PubMed Coblijn UK, Goucham AB, Lagarde SM, et al. Development of ulcer disease after Roux-en-Y gastric bypass, incidence, risk factors, and patient presentation: a systematic review. Obes Surg. 2014;24(2):299–309.PubMed
16.
Zurück zum Zitat Fringeli Y, Worreth M, Langer I. Gastrojejunal anastomosis complications and their management after laparoscopic Roux-en-Y gastric bypass. J Obes. 2015;2015:698425.PubMedPubMedCentral Fringeli Y, Worreth M, Langer I. Gastrojejunal anastomosis complications and their management after laparoscopic Roux-en-Y gastric bypass. J Obes. 2015;2015:698425.PubMedPubMedCentral
17.
Zurück zum Zitat Schulman AR, Abougergi MS, Thompson CC. H. pylori as a predictor of marginal ulceration: A nationwide analysis. Obesity (Silver Spring). 2017;25(3):522–6. Schulman AR, Abougergi MS, Thompson CC. H. pylori as a predictor of marginal ulceration: A nationwide analysis. Obesity (Silver Spring). 2017;25(3):522–6.
18.
Zurück zum Zitat Sverden E, Mattsson F, Sonden A, et al. Risk factors for marginal ulcer after gastric bypass surgery for obesity: a population-based cohort study. Ann Surg. 2016;263(4):733–7.PubMed Sverden E, Mattsson F, Sonden A, et al. Risk factors for marginal ulcer after gastric bypass surgery for obesity: a population-based cohort study. Ann Surg. 2016;263(4):733–7.PubMed
19.
Zurück zum Zitat Schreiber H, Ben-Meir A, Sonpal I, et al. Cigarette smoking, but not the presence of H. pylori, is associated with anastomotic ulcers in Roux-en-Y gastric bypass patients. Surg Obes Relat Dis. 2005;1(3):257. Schreiber H, Ben-Meir A, Sonpal I, et al. Cigarette smoking, but not the presence of H. pylori, is associated with anastomotic ulcers in Roux-en-Y gastric bypass patients. Surg Obes Relat Dis. 2005;1(3):257.
20.
Zurück zum Zitat Bhutta HY, Ashley SW. Hypertension and marginal ulceration after gastric bypass. J Surg Res. 2013;185(2):509–10.PubMed Bhutta HY, Ashley SW. Hypertension and marginal ulceration after gastric bypass. J Surg Res. 2013;185(2):509–10.PubMed
21.
Zurück zum Zitat Mason EE, Munns JR, Kealey GP, et al. Effect of gastric bypass on gastric secretion. 1977. Surg Obes Relat Dis. 2005;1(2):155–60. discussion 161-2PubMed Mason EE, Munns JR, Kealey GP, et al. Effect of gastric bypass on gastric secretion. 1977. Surg Obes Relat Dis. 2005;1(2):155–60. discussion 161-2PubMed
22.
Zurück zum Zitat Sidani S, Akkary E, Bell R. Catastrophic bleeding from a marginal ulcer after gastric bypass. JSLS. 2013;17(1):148–51.PubMedPubMedCentral Sidani S, Akkary E, Bell R. Catastrophic bleeding from a marginal ulcer after gastric bypass. JSLS. 2013;17(1):148–51.PubMedPubMedCentral
23.
Zurück zum Zitat Sapala JA, Wood MH, Sapala MA, et al. Marginal ulcer after gastric bypass: a prospective 3-year study of 173 patients. Obes Surg. 1998;8(5):505–16.PubMed Sapala JA, Wood MH, Sapala MA, et al. Marginal ulcer after gastric bypass: a prospective 3-year study of 173 patients. Obes Surg. 1998;8(5):505–16.PubMed
24.
Zurück zum Zitat Dallal RM, Bailey LA. Ulcer disease after gastric bypass surgery. Surg Obes Relat Dis. 2006;2(4):455–9.PubMed Dallal RM, Bailey LA. Ulcer disease after gastric bypass surgery. Surg Obes Relat Dis. 2006;2(4):455–9.PubMed
25.
Zurück zum Zitat Hedberg J, Hedenstrom H, Nilsson S, et al. Role of gastric acid in stomal ulcer after gastric bypass. Obes Surg. 2005;15(10):1375–8.PubMed Hedberg J, Hedenstrom H, Nilsson S, et al. Role of gastric acid in stomal ulcer after gastric bypass. Obes Surg. 2005;15(10):1375–8.PubMed
26.
Zurück zum Zitat Gribsholt SB, Pedersen AM, Svensson E, et al. Prevalence of self-reported symptoms after gastric bypass surgery for obesity. JAMA Surg. 2016;151(6):504–11.PubMed Gribsholt SB, Pedersen AM, Svensson E, et al. Prevalence of self-reported symptoms after gastric bypass surgery for obesity. JAMA Surg. 2016;151(6):504–11.PubMed
27.
Zurück zum Zitat Subhani M, Rizvon K, Mustacchia P. Endoscopic evaluation of symptomatic patients following bariatric surgery: a literature review. Diagn Ther Endosc. 2012;2012:753472.PubMedPubMedCentral Subhani M, Rizvon K, Mustacchia P. Endoscopic evaluation of symptomatic patients following bariatric surgery: a literature review. Diagn Ther Endosc. 2012;2012:753472.PubMedPubMedCentral
28.
Zurück zum Zitat Csendes A, Torres J, Burgos AM. Late marginal ulcers after gastric bypass for morbid obesity. Clinical and endoscopic findings and response to treatment. Obes Surg. 2011;21(9):1319–22.PubMed Csendes A, Torres J, Burgos AM. Late marginal ulcers after gastric bypass for morbid obesity. Clinical and endoscopic findings and response to treatment. Obes Surg. 2011;21(9):1319–22.PubMed
29.
Zurück zum Zitat Csendes A, Smok G, Burgos AM, et al. Prospective sequential endoscopic and histologic studies of the gastric pouch in 130 morbidly obese patients submitted to Roux-en-Y gastric bypass. Arq Bras Cir Dig. 2012;25(4):245–9.PubMed Csendes A, Smok G, Burgos AM, et al. Prospective sequential endoscopic and histologic studies of the gastric pouch in 130 morbidly obese patients submitted to Roux-en-Y gastric bypass. Arq Bras Cir Dig. 2012;25(4):245–9.PubMed
30.
Zurück zum Zitat Lanas A, Chan FKL. Peptic ulcer disease. Lancet. 2017;390(10094):613–24. Lanas A, Chan FKL. Peptic ulcer disease. Lancet. 2017;390(10094):613–24.
31.
Zurück zum Zitat Wallace JL. Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn't the stomach digest itself? Physiol Rev. 2008;88(4):1547–65.PubMed Wallace JL. Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn't the stomach digest itself? Physiol Rev. 2008;88(4):1547–65.PubMed
32.
Zurück zum Zitat Chaves LC, Borges IK, Souza MD, et al. Inflammatory disorders associated with Helicobacter pylori in the Roux-en-Y bypass gastric pouch. Arq Bras Cir Dig. 2016;29Suppl 1(Suppl 1):31–4.PubMed Chaves LC, Borges IK, Souza MD, et al. Inflammatory disorders associated with Helicobacter pylori in the Roux-en-Y bypass gastric pouch. Arq Bras Cir Dig. 2016;29Suppl 1(Suppl 1):31–4.PubMed
33.
Zurück zum Zitat Hartin Jr CW, ReMine DS, Lucktong TA. Preoperative bariatric screening and treatment of Helicobacter pylori. Surg Endosc. 2009;23(11):2531–4.PubMed Hartin Jr CW, ReMine DS, Lucktong TA. Preoperative bariatric screening and treatment of Helicobacter pylori. Surg Endosc. 2009;23(11):2531–4.PubMed
34.
Zurück zum Zitat Schirmer B, Erenoglu C, Miller A. Flexible endoscopy in the management of patients undergoing Roux-en-Y gastric bypass. Obes Surg. 2002;12(5):634–8.PubMed Schirmer B, Erenoglu C, Miller A. Flexible endoscopy in the management of patients undergoing Roux-en-Y gastric bypass. Obes Surg. 2002;12(5):634–8.PubMed
35.
Zurück zum Zitat Rawlins L, Rawlins MP, Brown CC, et al. Effect of helicobacter pylori on marginal ulcer and stomal stenosis after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2013;9(5):760–4.PubMed Rawlins L, Rawlins MP, Brown CC, et al. Effect of helicobacter pylori on marginal ulcer and stomal stenosis after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2013;9(5):760–4.PubMed
36.
Zurück zum Zitat Ashrafian H, Toma T, Rowland SP, et al. Bariatric surgery or non-surgical weight loss for obstructive sleep apnoea? A systematic review and comparison of meta-analyses. Obes Surg. 2015;25(7):1239–50.PubMed Ashrafian H, Toma T, Rowland SP, et al. Bariatric surgery or non-surgical weight loss for obstructive sleep apnoea? A systematic review and comparison of meta-analyses. Obes Surg. 2015;25(7):1239–50.PubMed
37.
Zurück zum Zitat Kurata JH, Honda GD, Frankl H. The incidence of duodenal and gastric ulcers in a large health maintenance organization. Am J Public Health. 1985;75(6):625–9.PubMedPubMedCentral Kurata JH, Honda GD, Frankl H. The incidence of duodenal and gastric ulcers in a large health maintenance organization. Am J Public Health. 1985;75(6):625–9.PubMedPubMedCentral
38.
Zurück zum Zitat Kanotra R, Ahmed M, Patel N, et al. Seasonal variations and trends in hospitalization for peptic ulcer disease in the United States: a 12-year analysis of the nationwide inpatient sample. Cureus. 2016;8(10):e854.PubMedPubMedCentral Kanotra R, Ahmed M, Patel N, et al. Seasonal variations and trends in hospitalization for peptic ulcer disease in the United States: a 12-year analysis of the nationwide inpatient sample. Cureus. 2016;8(10):e854.PubMedPubMedCentral
39.
Zurück zum Zitat Dong WG, Cheng CS, Liu SP, et al. Epidemiology of peptic ulcer disease in Wuhan area of China from 1997 to 2002. World J Gastroenterol. 2004;10(22):3377–9.PubMedPubMedCentral Dong WG, Cheng CS, Liu SP, et al. Epidemiology of peptic ulcer disease in Wuhan area of China from 1997 to 2002. World J Gastroenterol. 2004;10(22):3377–9.PubMedPubMedCentral
40.
Zurück zum Zitat Yang X, Guo Y, He J, et al. Estrogen and estrogen receptors in the modulation of gastrointestinal epithelial secretion. Oncotarget. 2017;8(57):97683–92.PubMedPubMedCentral Yang X, Guo Y, He J, et al. Estrogen and estrogen receptors in the modulation of gastrointestinal epithelial secretion. Oncotarget. 2017;8(57):97683–92.PubMedPubMedCentral
41.
Zurück zum Zitat Mehaffey JH, LaPar DJ, Clement KC, et al. 10-year outcomes after Roux-en-Y gastric bypass. Ann Surg. 2016;264(1):121–6.PubMed Mehaffey JH, LaPar DJ, Clement KC, et al. 10-year outcomes after Roux-en-Y gastric bypass. Ann Surg. 2016;264(1):121–6.PubMed
42.
Zurück zum Zitat Lent MR, Hayes SM, Wood GC, et al. Smoking and alcohol use in gastric bypass patients. Eat Behav. 2013;14(4):460–3.PubMed Lent MR, Hayes SM, Wood GC, et al. Smoking and alcohol use in gastric bypass patients. Eat Behav. 2013;14(4):460–3.PubMed
43.
Zurück zum Zitat Palermo M, Acquafresca PA, Rogula T, et al. Late surgical complications after gastric by-pass: a literature review. Arq Bras Cir Dig. 2015;28(2):139–43.PubMedPubMedCentral Palermo M, Acquafresca PA, Rogula T, et al. Late surgical complications after gastric by-pass: a literature review. Arq Bras Cir Dig. 2015;28(2):139–43.PubMedPubMedCentral
44.
Zurück zum Zitat Azagury DE, Abu Dayyeh BK, Greenwalt IT, et al. Marginal ulceration after Roux-en-Y gastric bypass surgery: characteristics, risk factors, treatment, and outcomes. Endoscopy. 2011;43(11):950–4.PubMed Azagury DE, Abu Dayyeh BK, Greenwalt IT, et al. Marginal ulceration after Roux-en-Y gastric bypass surgery: characteristics, risk factors, treatment, and outcomes. Endoscopy. 2011;43(11):950–4.PubMed
45.
Zurück zum Zitat Kular KS, Manchanda N, Rutledge R. Analysis of the five-year outcomes of sleeve gastrectomy and mini gastric bypass: a report from the Indian sub-continent. Obes Surg. 2014;24(10):1724–8.PubMed Kular KS, Manchanda N, Rutledge R. Analysis of the five-year outcomes of sleeve gastrectomy and mini gastric bypass: a report from the Indian sub-continent. Obes Surg. 2014;24(10):1724–8.PubMed
46.
Zurück zum Zitat Scheffel O, Daskalakis M, Weiner RA. Two important criteria for reducing the risk of postoperative ulcers at the gastrojejunostomy site after gastric bypass: patient compliance and type of gastric bypass. Obes Facts. 2011;4(Suppl 1):39–41.PubMedPubMedCentral Scheffel O, Daskalakis M, Weiner RA. Two important criteria for reducing the risk of postoperative ulcers at the gastrojejunostomy site after gastric bypass: patient compliance and type of gastric bypass. Obes Facts. 2011;4(Suppl 1):39–41.PubMedPubMedCentral
47.
Zurück zum Zitat Dittrich L, Schwenninger MV, Dittrich K, et al. Marginal ulcers after laparoscopic Roux-en-Y gastric bypass: analysis of the amount of daily and lifetime smoking on postoperative risk. Surg Obes Relat Dis. 2020;16(3):389–96.PubMed Dittrich L, Schwenninger MV, Dittrich K, et al. Marginal ulcers after laparoscopic Roux-en-Y gastric bypass: analysis of the amount of daily and lifetime smoking on postoperative risk. Surg Obes Relat Dis. 2020;16(3):389–96.PubMed
48.
Zurück zum Zitat Franke A, Teyssen S, Singer MV. Alcohol-related diseases of the esophagus and stomach. Dig Dis. 2005;23(3–4):204–13.PubMed Franke A, Teyssen S, Singer MV. Alcohol-related diseases of the esophagus and stomach. Dig Dis. 2005;23(3–4):204–13.PubMed
49.
Zurück zum Zitat Kaufman DW, Kelly JP, Wiholm BE, et al. The risk of acute major upper gastrointestinal bleeding among users of aspirin and ibuprofen at various levels of alcohol consumption. Am J Gastroenterol. 1999;94(11):3189–96.PubMed Kaufman DW, Kelly JP, Wiholm BE, et al. The risk of acute major upper gastrointestinal bleeding among users of aspirin and ibuprofen at various levels of alcohol consumption. Am J Gastroenterol. 1999;94(11):3189–96.PubMed
50.
Zurück zum Zitat Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321(7258):405–12.PubMedPubMedCentral Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321(7258):405–12.PubMedPubMedCentral
51.
Zurück zum Zitat Adler AI, Stratton IM, Neil HA, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ. 2000;321(7258):412–9.PubMedPubMedCentral Adler AI, Stratton IM, Neil HA, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ. 2000;321(7258):412–9.PubMedPubMedCentral
52.
Zurück zum Zitat Weisman SM, Graham DY. Evaluation of the benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular and cerebrovascular events. Arch Intern Med. 2002;162(19):2197–202.PubMed Weisman SM, Graham DY. Evaluation of the benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular and cerebrovascular events. Arch Intern Med. 2002;162(19):2197–202.PubMed
53.
Zurück zum Zitat Uemura N, Sugano K, Hiraishi H, et al. Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: the results from the MAGIC study. J Gastroenterol. 2014;49(5):814–24.PubMed Uemura N, Sugano K, Hiraishi H, et al. Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: the results from the MAGIC study. J Gastroenterol. 2014;49(5):814–24.PubMed
54.
Zurück zum Zitat Pantea M, Negovan A, Voidazan S, et al. Statins and gastroduodenal endoscopic lesions: a case-control study. Medicine (Baltimore). 2018;97(50):e13579. Pantea M, Negovan A, Voidazan S, et al. Statins and gastroduodenal endoscopic lesions: a case-control study. Medicine (Baltimore). 2018;97(50):e13579.
55.
Zurück zum Zitat Badillo R, Schmidt R, Mortensen EM, et al. Statin therapy and gastrointestinal hemorrhage: a retrospective cohort study with propensity score-matching. Pharmacoepidemiol Drug Saf. 2015;24(8):849–57.PubMed Badillo R, Schmidt R, Mortensen EM, et al. Statin therapy and gastrointestinal hemorrhage: a retrospective cohort study with propensity score-matching. Pharmacoepidemiol Drug Saf. 2015;24(8):849–57.PubMed
56.
Zurück zum Zitat Pyke O, Yang J, Cohn T, et al. Marginal ulcer continues to be a major source of morbidity over time following gastric bypass. Surg Endosc. 2018; Pyke O, Yang J, Cohn T, et al. Marginal ulcer continues to be a major source of morbidity over time following gastric bypass. Surg Endosc. 2018;
57.
Zurück zum Zitat Stulberg JJ, Haut ER. Practical guide to surgical data sets: healthcare cost and utilization project National Inpatient Sample (NIS). JAMA Surg. 2018;153(6):586–7.PubMed Stulberg JJ, Haut ER. Practical guide to surgical data sets: healthcare cost and utilization project National Inpatient Sample (NIS). JAMA Surg. 2018;153(6):586–7.PubMed
Metadaten
Titel
Which Factors Correlate with Marginal Ulcer After Surgery for Obesity?
verfasst von
Duarte-Chavez Rodrigo
Stoltzfus Jill
Marino Daniel
Chaput Kimberly
El Chaar Maher
Publikationsdatum
16.09.2020
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 12/2020
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-020-04960-z

Weitere Artikel der Ausgabe 12/2020

Obesity Surgery 12/2020 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.